(Q34318010)

1 August 2017

1 reference

title

Molecules and mechanisms of the graft-versus-leukaemia effect (English)

1 reference

1 August 2017

1 reference

Marie Bleakley

1

1 reference

1 August 2017

Stanley R Riddell

series ordinal

2

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

1 August 2017

published in

Nature Reviews Cancer

1 reference

1 August 2017

volume

4

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

371-380

1 reference

The current status of hematopoietic cell transplantation

1 August 2017

cites work

1 reference

The HLA system. First of two parts

31 March 2020

1 reference

Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant

31 March 2020

1 reference

Minor histocompatibility antigens in human stem cell transplantation

31 March 2020

1 reference

Treatment of murine leukaemia with X rays and homologous bone marrow; preliminary communication.

31 March 2020

1 reference

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

31 March 2020

1 reference

Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia

31 March 2020

1 reference

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

31 March 2020

1 reference

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

31 March 2020

1 reference

Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy

31 March 2020

1 reference

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma

31 March 2020

1 reference

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

31 March 2020

1 reference

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

31 March 2020

1 reference

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

31 March 2020

1 reference

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

31 March 2020

1 reference

Alloreactive killer cells: hindrance and help for haematopoietic transplants

31 March 2020

1 reference

Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease

31 March 2020

1 reference

Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes

31 March 2020

1 reference

CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells

31 March 2020

1 reference

The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism.

31 March 2020

1 reference

Identification of a novel HLA-B60-restricted T cell epitope of the minor histocompatibility antigen HA-1 locus

31 March 2020

1 reference

Identification of a graft versus host disease-associated human minor histocompatibility antigen

31 March 2020

1 reference

The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein.

31 March 2020

1 reference

The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein

31 March 2020

1 reference

The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing

31 March 2020

1 reference

A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia.

31 March 2020

1 reference

A human minor histocompatibility antigen resulting from differential expression due to a gene deletion

31 March 2020

1 reference

Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigens

31 March 2020

1 reference

Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein

31 March 2020

1 reference

The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition

31 March 2020

1 reference

The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen.

31 March 2020

1 reference

The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease.

31 March 2020

1 reference

Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation

31 March 2020

1 reference

Acute graft-versus-host disease does not require alloantigen expression on host epithelium

31 March 2020

1 reference

Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation

31 March 2020

1 reference

Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease

31 March 2020

1 reference

Absence of statistically significant correlation between disparity for the minor histocompatibility antigen-HA-1 and outcome after allogeneic hematopoietic cell transplantation

31 March 2020

1 reference

Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia

31 March 2020

1 reference

Induction of HA-1-specific cytotoxic T-cell clones parallels the therapeutic effect of donor lymphocyte infusion

31 March 2020

1 reference

Abnormal expression of apoptosis-related genes in haematological malignancies: overexpression of MYC is poor prognostic sign in mantle cell lymphoma.

31 March 2020

1 reference

Bi-directional allelic recognition of the human minor histocompatibility antigen HB-1 by cytotoxic T lymphocytes

31 March 2020

1 reference

The genetic program of hematopoietic stem cells

31 March 2020

1 reference

Reliable prediction of T-cell epitopes using neural networks with novel sequence representations

31 March 2020

1 reference

Disparity for a newly identified minor histocompatibility antigen, HA-8, correlates with acute graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling.

31 March 2020

1 reference

In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens

31 March 2020

1 reference

Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants

31 March 2020

1 reference

Identification of human telomerase reverse transcriptase-derived peptides that induce HLA-A24-restricted antileukemia cytotoxic T lymphocytes

31 March 2020

1 reference

The shared tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T cells

31 March 2020

1 reference

Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies

31 March 2020

1 reference

WT1 proteins: functions in growth and differentiation

31 March 2020

1 reference

Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation.

31 March 2020

1 reference

Identification of a novel WT1-derived peptide which induces human leucocyte antigen-A24-restricted anti-leukaemia cytotoxic T lymphocytes

31 March 2020

1 reference

Human cytotoxic T lymphocytes specific for Wilms' tumor antigen-1 inhibit engraftment of leukemia-initiating stem cells in non-obese diabetic-severe combined immunodeficient recipients

31 March 2020

1 reference

Immunocytochemical and flow cytometric detection of proteinase 3 (myeloblastin) in normal and leukaemic myeloid cells

31 March 2020

1 reference

Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells.

31 March 2020

1 reference

Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia

31 March 2020

1 reference

Interferon-alpha, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia

31 March 2020

1 reference

Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones

31 March 2020

1 reference

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

31 March 2020

1 reference

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

31 March 2020

1 reference

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

31 March 2020

1 reference

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

31 March 2020

1 reference

Efficient induction of minor histocompatibility antigen HA-1-specific cytotoxic T-cells using dendritic cells retrovirally transduced with HA-1-coding cDNA

31 March 2020

1 reference

Generation of bcr-abl specific cytotoxic T-lymphocytes by using dendritic cells pulsed with bcr-abl (b3a2) peptide: its applicability for donor leukocyte transfusions in marrow grafted CML patients

31 March 2020

1 reference

Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay.

31 March 2020

1 reference

In vivo migration and function of transferred HIV-1-specific cytotoxic T cells

31 March 2020

1 reference

Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes

31 March 2020

1 reference

Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer

31 March 2020

1 reference

Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region

31 March 2020

1 reference

Adoptive-cell-transfer therapy for the treatment of patients with cancer

31 March 2020

1 reference

Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15.

31 March 2020

1 reference

Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression

31 March 2020

1 reference

Expression of cutaneous lymphocyte-associated antigen by CD8(+) T cells specific for a skin-tropic virus

31 March 2020

1 reference

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency

31 March 2020

1 reference

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

31 March 2020

1 reference

T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients

31 March 2020

1 reference

A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease

31 March 2020

1 reference

Pharmacologically regulated Fas-mediated death of adoptively transferred T cells in a nonhuman primate model.

31 March 2020

1 reference

Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease

31 March 2020

1 reference

Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC1365

1 reference

Dimensions Publication ID

1 August 2017

1042309842

0 references

1 reference